PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
53.86
ESG score 80-90% of RIGL's 60.88. Walter Schloss would scrutinize governance quality and regulatory exposure.
51.34
Environmental score 80-90% of RIGL's 59.76. Walter Schloss would scrutinize carbon exposure and transition planning.
52.89
Social score 80-90% of RIGL's 65.58. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
57.36
Similar governance score to RIGL's 57.30. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.